Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection
Traditional meniscectomy or suture for meniscal tear usually leads to failed self-healing, cartilage degeneration and worse osteoarthritis. The strategies that facilitate the healing process of torn meniscus and safeguard knee cartilage against degeneration will be promising for clinical therapy. Th...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006424003193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850260762219511808 |
|---|---|
| author | Simiao Kang Xin Shi Yong Chen Lin Zhang Quanbo Liu Ziyang Lin Hongbin Lu Haile Pan |
| author_facet | Simiao Kang Xin Shi Yong Chen Lin Zhang Quanbo Liu Ziyang Lin Hongbin Lu Haile Pan |
| author_sort | Simiao Kang |
| collection | DOAJ |
| description | Traditional meniscectomy or suture for meniscal tear usually leads to failed self-healing, cartilage degeneration and worse osteoarthritis. The strategies that facilitate the healing process of torn meniscus and safeguard knee cartilage against degeneration will be promising for clinical therapy. The CD56+ umbilical cord mesenchymal stem cells (UCSCs) (CD56+UCSCs) were sorted from Wharton's jelly using flow cytometer. Then, the modified decellularized Wharton's Jelly hydrogel (DWJH) was combined with isolated CD56+Exos from CD56+UCSCs to fabricate DWJH/CD56+Exos. The in vitro studies were performed to characterize the DWJ (decellularized Wharton's Jelly). The injectability and rheological properties were assessed by shear rate and frequency sweep analysis. The biocompatibility and chondrogenic differentiation inducibility of DWJH/CD56+Exos were performed on human bone marrow mesenchymal stem cells (hBMSCs) and RAW 264.7 cells. The release dynamics was evaluated in vitro and in vivo experiments. As for the in vivo experiments, the operated rats that subjected to a 2 mm full-thickness longitudinal tear in right medial anterior meniscus were injected a single dose of DWJH/CD56+Exos. At 4 and 8 weeks postoperatively, torn meniscus healing and articular cartilage degeneration were evaluated by hematoxylin and eosin (H&E), safranin O/fast green (SO&FG), and Sirius red staining. In in vitro experiments, the injectable DWJH/CD56+Exos demonstrated excellent biocompatibility, exosome releasing efficiency, injectable property and chondrogenic inducibility. The results of in vivo experiments revealed that DWJH/CD56+Exos degraded over time, promoted meniscal chondrogenesis, organized meniscal extracellular matrix remodeling, safeguard articular cartilage and inhibited secondary cartilage degeneration, which accelerated further facilitated torn meniscus healing. The novel injectable DWJH/CD56+Exos promoted meniscal tear healing by promoting meniscal chondrogenesis, safeguarding articular cartilage, and inhibiting secondary cartilage degeneration. |
| format | Article |
| id | doaj-art-1cf993fadc744aefaf178c53c63c1ca0 |
| institution | OA Journals |
| issn | 2590-0064 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Materials Today Bio |
| spelling | doaj-art-1cf993fadc744aefaf178c53c63c1ca02025-08-20T01:55:34ZengElsevierMaterials Today Bio2590-00642024-12-012910125810.1016/j.mtbio.2024.101258Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protectionSimiao Kang0Xin Shi1Yong Chen2Lin Zhang3Quanbo Liu4Ziyang Lin5Hongbin Lu6Haile Pan7Department of Sports Medicine and Joint Arthroplasty, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, ChinaDepartment of Sports Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Sports Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Sports Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaKey Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Sports Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Sports Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, China; Hunan Engineering Research Center of Sports and Health, Changsha, China; Mobile Health Ministry of Education, China Mobile Joint Laboratory, Changsha, China; Xiangya Hospital International Chinese Musculoskeletal Research Society Sports Medicine Research Centre, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China; Corresponding author. Xiangya Hospital, No. 87, Xiangya Road, Kaifu District, Changsha, 410008, ChinaDepartment of Sports Medicine and Joint Arthroplasty, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China; Corresponding author. Department of Sports Medicine and Joint Arthroplasty, Second Affiliated Hospital of Harbin Medical University, No. 246 Baojian Road, Harbin, 150086, China.Traditional meniscectomy or suture for meniscal tear usually leads to failed self-healing, cartilage degeneration and worse osteoarthritis. The strategies that facilitate the healing process of torn meniscus and safeguard knee cartilage against degeneration will be promising for clinical therapy. The CD56+ umbilical cord mesenchymal stem cells (UCSCs) (CD56+UCSCs) were sorted from Wharton's jelly using flow cytometer. Then, the modified decellularized Wharton's Jelly hydrogel (DWJH) was combined with isolated CD56+Exos from CD56+UCSCs to fabricate DWJH/CD56+Exos. The in vitro studies were performed to characterize the DWJ (decellularized Wharton's Jelly). The injectability and rheological properties were assessed by shear rate and frequency sweep analysis. The biocompatibility and chondrogenic differentiation inducibility of DWJH/CD56+Exos were performed on human bone marrow mesenchymal stem cells (hBMSCs) and RAW 264.7 cells. The release dynamics was evaluated in vitro and in vivo experiments. As for the in vivo experiments, the operated rats that subjected to a 2 mm full-thickness longitudinal tear in right medial anterior meniscus were injected a single dose of DWJH/CD56+Exos. At 4 and 8 weeks postoperatively, torn meniscus healing and articular cartilage degeneration were evaluated by hematoxylin and eosin (H&E), safranin O/fast green (SO&FG), and Sirius red staining. In in vitro experiments, the injectable DWJH/CD56+Exos demonstrated excellent biocompatibility, exosome releasing efficiency, injectable property and chondrogenic inducibility. The results of in vivo experiments revealed that DWJH/CD56+Exos degraded over time, promoted meniscal chondrogenesis, organized meniscal extracellular matrix remodeling, safeguard articular cartilage and inhibited secondary cartilage degeneration, which accelerated further facilitated torn meniscus healing. The novel injectable DWJH/CD56+Exos promoted meniscal tear healing by promoting meniscal chondrogenesis, safeguarding articular cartilage, and inhibiting secondary cartilage degeneration.http://www.sciencedirect.com/science/article/pii/S2590006424003193Meniscal tearDecellularized Wharton's jelly hydrogelCD56Umbilical cord mesenchymal stem cellExosome |
| spellingShingle | Simiao Kang Xin Shi Yong Chen Lin Zhang Quanbo Liu Ziyang Lin Hongbin Lu Haile Pan Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection Materials Today Bio Meniscal tear Decellularized Wharton's jelly hydrogel CD56 Umbilical cord mesenchymal stem cell Exosome |
| title | Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection |
| title_full | Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection |
| title_fullStr | Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection |
| title_full_unstemmed | Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection |
| title_short | Injectable decellularized Wharton's jelly hydrogel containing CD56+ umbilical cord mesenchymal stem cell-derived exosomes for meniscus tear healing and cartilage protection |
| title_sort | injectable decellularized wharton s jelly hydrogel containing cd56 umbilical cord mesenchymal stem cell derived exosomes for meniscus tear healing and cartilage protection |
| topic | Meniscal tear Decellularized Wharton's jelly hydrogel CD56 Umbilical cord mesenchymal stem cell Exosome |
| url | http://www.sciencedirect.com/science/article/pii/S2590006424003193 |
| work_keys_str_mv | AT simiaokang injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT xinshi injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT yongchen injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT linzhang injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT quanboliu injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT ziyanglin injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT hongbinlu injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection AT hailepan injectabledecellularizedwhartonsjellyhydrogelcontainingcd56umbilicalcordmesenchymalstemcellderivedexosomesformeniscustearhealingandcartilageprotection |